Facts from the filing
Form 4 · Non-derivative, table I- Disclosed value
- $1,123.66Shares × reported price
- Shares traded
- 11,236,631Class A Common Stock, $0.0001 par value per share
- Price per share
- $0.00Reported price. Read footnotes for ranges.
- % of reported position traded
- UnavailableThis security and ownership context
- Holdings after
- 23,188,345Indirect · By Daewoong Pharmaceutical Co., Ltd.
- Trade date
- Oct 30, 2026Derivative exercise
- Filed
- Nov 10, 2026, 11:35 AM ET11-day reporting delay
- Accession
- 0001213900-26-117865Code X · Transaction 396739
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.